MUTATIONS APP 27269971 GRCh37/hg19 rs770773038 A T 25897659 GRCh38/hg38 A T Exon 16 Coding Unknown, but predicted deleterious in silico (PHRED-scaled CADD score = 25.8). Unknown. N660Y Alzheimer's Disease: Not ClassifiedProbable VaD Data on the carrier(s) of t
PAPER Sambashivan S, Freeman MR
Curr Opin Neurobiol. 2021 Aug;69:247-255. Epub 2021 Jun 25 PubMed.
JOB 2025-03-07 Employer AlzForum Foundation Inc. Contact Apply here. Description The biocuration scientist is responsible for the ongoing curation of scientific databases and directories in the Alzforum website (www.alzforum.org). Alzforum provides a high-quality scien
THERAPEUTICS Nura Bio™ Inc. Small Molecule Other In August 2023, Nura Bio began Phase 1 with an ascending-dose safety trial in 66 healthy volunteers. Single doses of 50, 100, 175, 300, 450, and 600 mg, or 10 days of repeated dosing were compared to placebo. Besides sa
PAPER Wen S, Ju Z, Wang Y, Zuo CT, Sun X, Zheng T
ACS Appl Mater Interfaces. 2025 Mar 5;17(9):13461-13470. Epub 2025 Feb 19 PubMed.
PAPER Ludolph A, Klose V, Dreyhaupt J, Del Tredici K, Braak H
J Neurol. 2025 Mar 6;272(3):253. PubMed.
PAPER Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Mohammed SG
Behav Brain Res. 2025 Mar 3;484:115524. Epub 2025 Mar 3 PubMed.
PAPER Preziuso A, Serfilippi T, Toujani M, Terenzi V, Amoroso S, Magi S, Lariccia V, Piccirillo S
FEBS J. 2025 Mar 5; Epub 2025 Mar 5 PubMed.
PAPER Qiang Q, Skudder-Hill L, Toyota T, Huang Z, Wei W, Adachi H, Alzheimer’s Disease Neuroimaging Initiative
Neurobiol Aging. 2025 Feb 27;150:9-18. Epub 2025 Feb 27 PubMed.
PAPER Pikija S, Toma A, Radlberger R, Griessenauer CJ, Hecker C, Trinka E, Ki PH, Kraus T, Weis S, Wermer MJ, van Etten ES, Kaushik K
Eur J Neurol. 2025 Mar;32(3):e70091. PubMed.
PAPER Alpaugh M, Lantero-Rodriguez J, Benedet AL, Manseau U, Boutin M, Maiuri M, Denis HL, Masnata M, Fazal SV, Chouinard S, Rosa-Neto P, Barker RA, Blennow K, Zetterberg H, Labib R, Cicchetti F
J Neurol. 2025 Mar 6;272(3):254. PubMed.